Results. Injured groups demonstrated mechanical hypersensitivity 1-30 days post-operatively. Photobiomodulation-treated animals began to recover after two treatments; at day 26, mechanical sensitivity reached baseline. Peripheral nerve injury caused region-specific macrophages/microglia activation along spinothalamic and dorsal-column medial lemniscus pathways. A pro-inflammatory microglial marker was expressed in the spinal cord of injured rats compared to photobiomodulation-treated and sham group. Photobiomodulation-treated dorsal root ganglion macrophages expressed anti-inflammatory markers.
Introduction
Neuropathic pain is a common, debilitating disorder that affects up to six million Americans [1] . The etiology of neuropathic pain is not completely understood but is associated with diabetes, exposure to toxins, genetic and immune mediated disorders, or physical trauma to nerve tissue. The mechanisms of neuropathic pain are diverse and multifaceted. In the past decade, research efforts have focused on the interaction between the damage to the neuron and inflammatory processes that occur as a result of the damage. Injury to peripheral nerves results in a release of pro-inflammatory factors that activate resident macrophages and microglia along ascending somatosensory pathways. Activated macrophages and microglia release a host of inflammatory factors that contribute to enhanced sensitivity of nociceptors both peripherally and centrally, resulting in the initiation and maintenance of neuropathic pain [2, 3] .
Macrophages and microglia exhibit a range of responses to injury,fromrestingtopro-inflammatorytoanti-inflammatory. Their activated states have been broadly defined as classical activation (M1) and alternative activation (M2). M1 macrophages/microglia are associated with production of proinflammatory cytokines (IFN-b, IL-6, TNF-a, IL-1b), chemokines (CCL2), receptors (CCR2), and antigen presentation molecules(CD86),andproduceandreleasereactiveoxygen species and inducible nitric oxide synthase (iNOS) [4] [5] [6] [7] . In contrast, M2 macrophages/microglia produce antiinflammatory cytokines (IL-10, TGF-b) and a different subset of antigen presenting molecules (CD206) [5] [6] [7] [8] . M2 macrophages/microglia favor production of arginase-1 over iNOS, resultingindownregulationofdamagingnitricoxide,andproductionoffactorsinvolvedinregenerationandwoundhealing [9] . Few existing studies evaluate the role of macrophage/ microglial polarization in models of neuropathic pain [10, 11] . Thoughthemechanismsarenotwellunderstood,theassociation of M1 activation with increased pro-inflammatory factors, such as TNF-a and IL-1b, which are implicated in increasing sensitivity of somatosensory neurons, may indicate that a shift to M1 activation results in mechanical hypersensitivityassociatedwithneuropathicpain.
A number of pharmacologic and interventional treatments are used to treat neuropathic pain; however, less than half of patients report satisfactory relief of their symptoms [12] . Low level light therapy, now referred to as photobiomodulation (PBM) therapy, is defined as a form of light therapy that utilizes non-ionizing forms of light sources, including lasers, light emitting diodes (LED), and broad-band light, in the visible and infrared spectrum. It is a non-thermal process involving endogenous chromophores eliciting photophysical (i.e., linear and non-linear) and photochemical events at various biological scales. This process results in beneficial therapeutic outcomes including but not limited to the alleviation of pain or inflammation, immunomodulation, and promotion of wound healing and tissue regeneration [13] . The absorption of photons from red and near infrared light occurs at the terminal enzyme in the mitochondrial respiratory chain, cytochrome c oxidase (CCO) [14, 15] . Recent reports with updated spectrophotometric equipment confirm that CCO absorbs light throughout the near infrared range, up to 1000 nm wavelength [16] . The activation of CCO leads to several downstream events, such as increased production of ATP, cellular metabolic activity, and cell proliferation [15, 17, 18] . Photobiomodulation acts in part by causing an anti-inflammatory effect in the target tissue [19] [20] [21] [22] , and recent investigations suggest that PBM can alter microglial phenotypes across the M1/M2 spectrum in a dose-dependent manner [23] . Photobiomodulation can reduce pain and improve function in painful conditions such as carpal tunnel syndrome and arthritis [24, 25] . A systematic review of 16 randomized controlled trials (total N ¼ 820) found that PBM reduced acute and chronic neck pain [26] . As such, PBM has promise as an effective treatment for neuropathic pain associated with inflammation.
The purpose of the present study was to characterize the temporal-spatial activation and polarization of macrophages and microglia along ascending somatosensory pathways, and to use PBM to modulate the inflammatory response to anti-inflammatory macrophage/microglial activation, thereby reducing mechanical hypersensitivity.
Methods

Animals and Experimental Groups
All procedures were performed in accordance with the Guide for the Care and Use of Laboratory Animals, NIH Publication 86-23, and were approved by the Institutional Animal Care and Use Committee at the
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Uniformed Services University of the Health Sciences (APG-11-808). A total of 33 adult, male Sprague-Dawley rats (weight range at day of surgery 300 to 350 g; Charles River Laboratories Incorporated, Frederick, MD) were randomly assigned to groups: sham surgery (N ¼ 13), SNI surgery (N ¼ 13), and SNI þ PBM treatment (N ¼ 7). The minimal number of animals was chosen, consistent with appropriate scientific and statistical requirements. Because PBM treatment did not start until day 7 after surgery, data from the SNI group were used as a referent for days 3 and 7 PBM groups. The rats were pair-housed in clear plastic cages (42.5 cm Â 20.5 cm Â 20 cm) with hardwood chip bedding (Teklad Sani-chips, Harlan Teklad Diets, Madison, WI) within their experimental group. The rats were exposed to a 12-hour reversed light/dark cycle with lights on at 1800 hours and off at 0600 hours. Rats were allowed food (Teklad 18% Protein Rodent Diet, Harlan) and tap water ad libitum.
Spared Nerve Injury and Sham Surgery
The spared nerve injury (SNI) model of neuropathic pain was used. Rats were anesthetized by inhalation of isoflurane (5% for induction and 0.5-3% for maintenance) in 100% flow of O 2 . After shaving the surgical site and cleansing the skin with betadine, a 1-1 1 =2 inch incision was made on the lateral left thigh with a surgical scalpel. The cranial and caudal parts of the biceps femoris muscle were separated and held apart by retractors to expose the sciatic nerve and its three terminal branches: the sural, common peroneal, and tibial nerves. The common peroneal and tibial nerves were tightly ligated with 6-0 nonabsorbable nylon suture and 2-4 mm of each nerve distal to the ligation was cut and removed. Any stretching or contact with the intact sural nerve was avoided. The muscle and skin were closed in two layers, with skin closed with hidden stitches (Monocryl Plus 6-0 suture) to avoid any opening of the wound by biting. The sham surgery group had the sciatic nerve exposed, but left intact. Animals were returned to their cages following surgery and observed during recovery. Table 1 illustrates the experimental scheme for surgery, treatment, behavioral testing and bioassay testing.
Behavior
Mechanical Allodynia. Hypersensitivity to mechanical stimulation was used as a measure of mechanical allodynia. An electronic von Frey (Bioseb, Chaville, France) consisting of a hand-held force transducer fitted with a plastic tip was used to test the mechanical withdrawal threshold of the hind paw. The rats were placed in an inverted plastic box on an elevated metal grid to allow for stimulation of the lateral plantar surface of the hind paw. The rats were allowed to acclimate to the testing situation for 15 minutes prior to each behavioral measurement. The plastic tip of the transducer was applied perpendicularly to the plantar surface of the hind paw in the region innervated by the intact sural nerve, and pressure applied with increasing force until the rat withdrew the paw. The device recorded the threshold as the lowest force (from 0-500 grams in 0.1 gram intervals) at which a brisk withdraw of the hind paw was elicited. The test was repeated three times with a 5-minute interval between each measurement, and the mean of the three measurements was computed for analysis [27, 28] .
Open Field Activity. Open field activity (OFA) measured general locomotor activity and depression-and anxietyrelated behaviors [29] . OFA was measured using AccuScan Superflex Sensor Version 2.2 infrared photocell system in the AccuScan Instrument testing chamber. The ventilated, PlexiglasV R chambers (40 cm Â 40 cm Â 30 cm; AccuScan Instruments Incorporated, Columbus, OH) were located in a dedicated room to decrease interruptions during testing. The system captures horizontal and vertical movement of the animal with three, paired 16-photocell Superflex Sensors, and then transmits the data to the AccuScan Superflex Node [30, 31] . Data are then aggregated and processed by AccuScan Fusion Software (Version 3.4). Animals were allowed to acclimate to the chambers for one hour on a day prior to their baseline measurements. Baseline measurements were conducted on the day before surgery, and then repeated 18 days after surgery. All behavioral measures were obtained during the animals' active period (dark cycle).
Photobiomodulation Therapy
Our laboratory has extensive experience demonstrating effectiveness with using 980 nm continuous wavelength light with nerve both in vitro and in vivo. Previous experiments have established that effective parameters of 980 nm continuous wavelength light used in vivo could be effectively translated to in vitro nerve injury. We have effectively used 980 nm continuous wavelength light to support nerve regeneration post-transection [32] . PBM treatment parameters in this study were based on these previous reports on what we knew to be effective for treating nerve with 980 nm continuous wave light.
PBM treatment was delivered with a 980 nm wavelength diode laser (Lite Cure, LLC, Dover, DE). Laser irradiation was delivered through a flexible optical fiber threaded through the hand piece, which contained a 2.75 cm diameter rolling glass ball. PBM treatment occurred every other day beginning on day 7 post-surgery. Mechanical allodynia and macrophage activation and recruitment along the peripheral nerve and DRG occurs by day 3 following SNI, with microglial activation in the spinal cord occurring by day 7 [33] [34] [35] [36] . The purpose of this treatment schedule was to determine the impact of PBM on established cellular and behavioral changes caused by SNI, and not to be used as pain prevention measure, in order to more closely relate to clinical neuropathic pain condition. Because peripheral nerve injury causes changes along the entire sensory pathway, PBM was applied to corresponding skin of the receptive field of the sural nerve and adjacent receptive fields, and the region of the DRG and spinal cord segments of the injured nerves transcutaneously. The rats were lightly anesthetized with isoflurane (5% in 100% flow O 2 ) and were treated at the lateral surface of the hind paw ipsilateral to the surgery, over the L4/L5 DRG, and over the L4/L5 spinal cord segments (located at the T13-L1 level of the vertebra).
The location of the T13-L1 level of the vertebra was determined by palpating the last rib and following the rib to the vertebra. The L4/L5 DRG location was determined previously by measurements taken after dissection of the involved spinal cord region and DRGs of a similarly sized Sprague Dawley rat. For irradiation of the lateral surface of the hind paw, an output power of 1W, for a 20 second treatment time with the probe set at 41 cm above the lateral hind paw surface was used (20J total). At this distance, the 2.75 cm diameter massage ball created a spot size of 7 cm diameter, with the hind paw placed in the center of the spot (0.519 J/cm 2 ). For transcutaneous irradiation at the DRG, an output power of 4.5W was applied in direct contact to shaved skin for 19 seconds (85.5J total); and for the spinal cord, an output power of 1.25W with an irradiation time of 19 seconds with the probe in contact with the skin was used (28.5J total). When PBM is used in direct contact with the skin, reporting light spot size is irrelevant due to the immediate transmission, scatter, and reflectance that occur. Using an infrared sensor card, the irradiation area can be detected and measured. The glass ball of the hand piece was placed in contact with the sensor card. The shape of the area of irradiation was circular and had a diameter of 4 cm. The circular area consisted of a bright center with a 1 cm diameter and a halo, with the width of 1.5 cm. All treatment regions had an approximate power density of 43.25 mW/cm 2 at the target tissue. The power density was calculated based on actual measurements with a specially designed sensor that measured transmission at the target tissue in anesthetized rats. A small photo sensor (2.0 mm Â 2.5 mm) was sealed in a glass tube. The output voltage of the sensor was calibrated such that a reading of 1 mV represented a fluence rate of 1 mW/ cm2. All groups were handled similarly; SNI and sham rats were anesthetized but the laser was not turned on.
Immunohistochemistry
Quantitative immunohistochemistry was used to characterize general macrophage/microglial activation and M1/ M2 polarization. Samples were collected from the DRG, dorsal spinal cord, and the gracile nucleus in the medulla. These regions of the ascending afferent system were chosen for examination to coordinate with anticipated changes in the dorsal column-medial lemniscus (DC-ML) pathways related to the specific pain behavior of mechanical allodynia. Though focused on the DC-ML pathway, we anticipated inflammatory changes in both the spinal cord dorsal column (SCDC) and the spinal cord dorsal horn (SCDH), since axons from the DC-ML and spinothalamic tract (STT) are injured in the SNI mode. First order neurons from the STT synapse in the SCDH, as well as some collateral fibers from DC-ML axons, which synapse on inhibitory interneurons of the SCDH as part of modulation of pain transmission [37] . In the SNI model the DRG holds nerve cell bodies of injured and uninjured afferents, and medullary nuclei were included because they are the location for synapses of the primary neurons for DC-ML pathways [33, 34, 38, 39] .
After behavior was measured on days 3, 7, 14, and 30 post surgery, three animals from each group were lightly anesthetized with isoflurane (5% in 100% oxygen flow), fully anesthetized with sodium pentobarbital (50 mg/kg, 25 gauge needle) intraperitoneally, and then transcardially perfused with 0.1 M PBS, pH 7.4, followed by 4% paraformaldehyde in a phosphate buffer. Medulla (4 mm), spinal cord (15 mm), and DRG (1-2 mm) samples were dissected, post-fixed for 24 hours in 4% paraformaldehyde, and cryoprotected for 24 hours in 30% sucrose. The tissue samples were cut into 20 lm sections using a cryostat (Leica CM3050 S, Leica Biosystems, Wetzlar, Germany). Approximately 12 sections from each anatomical location from each rat were processed for each cell type under investigation. Immunolabeling with antibodies directed against general macrophages/microglia (Iba1) was done. Antibodies that identified M1 (CD86) and M2 macrophages/microglia (CD206) were used to identify activated and polarized macrophages and microglia. Negative controls, in which the sections were not incubated with the primary antibodies, were run for each cell type.
For assessment of the general macrophage/microglia activation, the sections were rehydrated (PBS 5 min Â
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2) and blocked with PBS with 10% goat serum for 15 minutes at room temperature. The tissue was incubated overnight at 4 C with Iba1 (rabbit polyclonal; 1:100; WAKO). For assessment of M1/M2 polarization, sections were rehydrated and blocked with PBS with 10% goat serum and 0.1% Triton X for 15 minutes at room temperature. The slides were then incubated with either primary antibodies against CD86 for 45 minutes at room temperature (M1; rabbit monoclonal; 6.5 ll/ml; Abcam, Cambridge, MA), or against CD206 for 1 hour at room temperature (M2; rabbit monoclonal, 1:1000: Abcam). All samples were then washed with PBS (5 min Â 4), then incubated with a secondary antibody conjugated with Alexa Fluor 488 (2.5 ll/ml Molecular Probes, Carlsbad, CA) at room temperature for 30 minutes-1 hour. After washing, they were coverslipped with Vectashield HardSet mounting medium with DAPI.
The sections were digitally photographed at 20X using a Nikon Eclipse 80i Advanced Research Microscope (Nikon Instruments, NY). The proportional area of tissue occupied by immunohistochemically stained cellular profiles within a defined target area was measured with NIS Elements Software (Version 4.1, Advanced Research, Nikon). Tissue regions were scanned and the proportion of the area that included positive immunolabeling was quantified. All image backgrounds were normalized to prevent bias by setting a standard exposure time.
Restrictions were set to exclude positive labeling of less than 10 pixels prior to quantitation.
Data Analysis
All results are presented as mean 6 standard error of the mean (SEM). The sample size for behavioral measurements in this proposed study was determined by the power procedure using a two-sample t test for mean difference. Behavioral data from Decosterd and Woolf's seminal article on the SNI model for neuropathic pain were used to determine the sample size needed to detect a difference in mechanical withdrawal threshold measurements from baseline to time points after surgery [34] . Mechanical allodynia results were evaluated by mixed model repeated measures two-way ANOVA using SAS for Windows, version 9.3 (SAS Institute, Cary, NC). One-way repeated measures ANOVA was used to analyze OFA data using SPSS Statistics, version 22 (IBM, Armonk, NY). Two-way ANOVA was used to compare means of immunohistochemistry analysis for interaction effects as well as effect of group and time using GraphPad PRISM 6.0 (GraphPad Software, Inc, La Jolla, CA). Sham and SNI groups were assessed at days 3, 7, 14 and 30 after surgery; because PBM treatment did not start until day 7 after surgery, the SNI group means were used as a referent group for days 3 and 7 PBM groups. The Bonferroni-Holm method was used to adjust for multiple comparisons. Two-tailed statistical significance was established as P < 0.05.
Results
Behavior
Mechanical Allodynia. There was no significant difference in mechanical hypersensitivity within the sham group over time. SNI and PBM groups demonstrated decreased mechanical withdrawal threshold at 1 day post-surgery (P < 0.0001); this level of increased sensitivity to mechanical stimulation was maintained in the SNI group for the duration of the experiment. After two treatments (day 10), the PBM group began to recover towards their baseline, demonstrating decreased sensitivity to mechanical stimulation compared to the injured group from day 10 until the end of the experiment at day 30 (P < 0.0001). At Day 26, the PBM group reached their baseline levels of sensitivity to mechanical stimulus (P ¼ 0.96) (Figure 1 ).
Open Field Activity. Open field activity analysis compared horizontal activity (general motor), vertical activity (depression), and center time/movement time (anxiety) at baseline and at day 18 after surgery. There was no significant effect for time in horizontal activity (P ¼ 0.581), vertical activity (P ¼ 0.345), or center time/ movement time (P ¼ 0.066). These findings indicate that the SNI did not impact movement involved in the withdrawal reflex, thereby validating the mechanical allodynia measure.
Iba1-Morphology
Dorsal Root Ganglia. Macrophages from sham group DRGs were present between DRG neurons and had round cell bodies at all time points (Figure 2A, 2C ). In the SNI group, macrophages were more numerous, displayed a larger cell body, and were flattened and surrounded the neuronal cell bodies and processes ( Figure  2B, 2D) . Macrophages in PBM group retained the injury morphology. Two-way ANOVA showed a significant group by time interaction in Iba1 expression in the DRG Figure 1 Mechanical withdrawal threshold. Sham vs PBM *P < 0.0001; PBM vs SNI þP < 0.001; Data in graph are presented as mean þ/À SEM.
(P ¼ 0.0044); the individual group (P < 0.0001) ( Figure  2E ) and time (P < 0.0001) ( Figure 2F ) effect were also significant. There was no difference in Iba1 expression between SNI and PBM groups. Macrophage activation and recruitment was significantly greater in the SNI group at day 7 and in both the SNI and PBM group at day 14 compared to the sham group (P ¼ 0.003); by post-operative day 30, the positive area returned to sham and baseline levels ( Figure 2E ). Within group analysis showed that the positively labeled area did not change significantly over time in the sham group ( Figure 2F ). , C) , those in SNI DRGs had larger, flattened cell bodies, and surrounded neuronal cell bodies (white '*'). Arrows indicate typical activated morphology. (E, F) Graphs show comparisons of quantification of Iba1-labeled macrophages in DRG sections between (E) and within groups (F) by 2-way ANOVA. There was a significant group by time interaction (P = 0.0044), as well as individual group (P < 0.0001) and time (P < 0.0001) effects. There are no samples from the PBM treatment group on day 3 and 7 because treatment did not begin until day 7. N ¼ 3 rats in each group. *P < 0.05 and **P < 0.01, P values corrected for multiple comparisons using Bonferroni-Holms technique. Data in graph are represented as mean þ/À SEM. Scale bar 100 lm.
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Spinal Cord. Microglial morphology in both the SCDH and SCDC was evaluated in the same fashion. There were few microglial cells visible in the SCDH/SCHC from the sham group; those present were in a ramified state, with small cell bodies and long, thin processes ( Figure  3A, 3C) . In both SNI and PBM samples, there were a greater number of microglia, with larger cell bodies and shorter, thicker processes ( Figure 3B, 3D, 3E) . C) . Image E shows typical activated morphology of microglia in SNI SCDH at 7 days post-operatively, 20x. Graphs show comparisons of quantification of Iba1-labeled microglia in SCDH (F, G) and SCDC (H, I) sections between and within groups by 2-way ANOVA. There was a significant group by time interaction in both SCDH and SCDC (P < 0.0001), as well as individual group and time effects (both P < 0.0001). There are no samples from the PBM treatment group on day 3 and 7 because treatment did not begin until day 7. N ¼ 3 rats in each group. *P < 0.05 and **P < 0.01, P values corrected for multiple comparisons using Bonferroni-Holms technique. Data in graph are represented as mean þ/À SEM. Scale bar 100 lm.
There was a significant group by time interaction for SCDH and SCDC (P < 0.0001), as well as significant individual effects of group ( Figure 3F, 3H ) and time ( Figure  3G , 3I) (P < 0.0001). Total area of microglia in both the SCDH and SCDC of the SNI group was significantly increased compared to sham at post-operative day 3 and 7 (P ¼ 0.003) (Figure F, H) . There was significantly higher Iba1-labeled microglia area in both SNI and PBM SCDC compared to sham at day 14 (P ¼ 0.003) ( Figure 3H ), but not in SCDH ( Figure 3F ). Within group analysis showed peak expression in both SCDH and SCDC of SNI samples at day 7 ( Figures 3G, 3I) . Figure 4 Iba1 expression in GN microglia. There was an increase in size and number of Iba1-labeled microglia in the GN of SNI (B, D) vs sham rats (A, C). This increase peaked at day 7 but was sustained until 30 days post-operatively (E). Graphs show comparisons of quantification of Iba1-labeled microglia in GN sections between (E) and within (F) groups by 2-way ANOVA. There was a significant group by time interaction as well as individual group and time effects (all P < 0.0001). There are no samples from the PBM treatment group on day 3 and 7 because treatment did not begin until day 7. N ¼ 3 rats in each group. *P < 0.05 and **P < 0.01 for sham vs SNI comparison, þP < 0.05 for sham vs PBM, and for SNI vs PBM. P values corrected for multiple comparisons using Bonferroni-Holms technique. Data in graph are represented as mean þ/À SEM. Scale bar 100 lm.
Gracile Nucleus. Iba1 expression in the GN also had a significant group by time interaction and individual group and time effect (P < 0.0001). Microglia in the GN had similar morphology to the spinal cord sections ( Figure  4A-D) . The SNI group had a significantly higher area of Iba1-labeled microglia than sham at post-operative day 3 and 7 (P ¼ 0.003). Iba1 expression was significantly higher in the PBM group (P ¼ 0.003) and SNI (P < 0.01) over sham at day 14 and in both SNI (P ¼ 0.003) and PBM (P ¼ 0.0221) groups compared to sham at day 30 ( Figure 4E ). Over time, the area of Iba1-labeled microglia peaked at day 7 in the SNI group ( Figure 4F) . At day 14, there were substantially fewer data points in the SNI group [19] than for other times and groups [30] [31] [32] [33] [34] [35] [36] [37] [38] . Sub-analyses of these data (day 14) did not result in significant differences between the SNI and sham group, however, these results should be interpreted cautiously due to the scarce data points included in the comparison.
Summary of Iba1 Expression. Overall, SNI resulted in regional-and time-specific significant increases in macrophage/microglia activation and recruitment along the DC-ML pathway (Table 2 ). In the PNS, macrophage activation was delayed until day 7, and resolved by day 30. SNI resulted in earlier activation of CNS microglia (by day 3); this activation was sustained until day 7 in the SCDH, day 14 in the SCDC, and day 30 in the GN.
M1/M2 Polarization
CD86 antibody was used to label the M1 phenotype of activated microglia and CD206 antibody was used for the M2 phenotype. Positive labeling with CD86 was found in spinal cord samples, but not DRG or GN samples ( Figure 5A -C) and CD206 labeling was detected only in DRG samples ( Figure 5D-F) .
Two-way ANOVA detected a significant group by time interaction, as well as a significant effect of group and time individually in both SCDH and SCDC CD86 expression (P < 0.0001). Spinal cord dorsal horn samples from the SNI group expressed significantly higher areas of CD86 labeled microglia at post-operative day 7 and 14 compared to sham (P ¼ 0.0018). Once PBM treatment began, the PBM treatment group did not differ from sham levels of CD86 expression in the SCDH. In the SCDC, CD86 expression was elevated in the SNI group at day 14 (P ¼ 0.0018) and remained significantly higher than both sham and PBM treatment groups at day 30 (P ¼ 0.0018). Sham and PBM treatment groups did not differ on CD86 expression at any time point (Figure 5G, 5H ).
There was a significant effect for both group by time interaction, and an individual effect for group and time factors in M2 macrophages expressing CD206 in the DRG (P < 0.0001). M2 macrophages were elevated in the PBM treatment group following the start of treatment, but not in the SNI or sham groups. Expression of CD206 peaked at day 14 (P ¼ 0.0018) and remained significantly elevated over sham (P ¼ 0.006) and SNI (P ¼ 0.0018) at day 30 ( Figure 5I ).
Injury to the peripheral nerve results in activation of the M1, pro-inflammatory, phenotype of microglia expressing CD86, in spinal cord dorsal horn and dorsal column ( Figure 5G, 5H) . The increase occurs first in the dorsal horn (7-14 days after injury), followed by increased activation in the dorsal column (14-30 days after injury). The M1 phenotype was not found to have an increase in either sham or PBM treated groups in the SCDH or SCDC. In DRG samples, M2 macrophages expressing CD206 were significantly elevated in the PBM treatment group, but not in the SNI or sham group ( Figure 5I ). The M2 shift peaked at day 14, 7 days after the start of treatment, and remained significantly elevated over sham and SNI groups at post-operative day 30.
Discussion
This study established that PBM effectively resolves mechanical hypersensitivity caused by peripheral nerve injury in the SNI model. There was a region-and timespecific activation of macrophages and microglia along the DC-ML pathway. Furthermore, this study established that peripheral nerve injury causes a shift to proinflammatory microglial activation in spinal cord, and that PBM results in anti-inflammatory macrophage activation in the DRG of injured animals.
Photobiomodulation as an Effective Treatment for Mechanical Hypersensitivity in SNI Model
These optimized PBM parameters effectively resolved mechanical hypersensitivity in SNI rats. The PBM treatment resulted in decreased hypersensitivity to mechanical stimulation after only two treatments. This decrease in hypersensitivity continued to resolve until postoperative day 26, when the mechanical allodynia measure returned to baseline. Previous studies using PBM in animal models of neuropathic pain have had similar positive results. Hsieh and colleagues [40] treated the skin over chronic constriction injury site in adult male Sprague-Dawley rats with PBM. Treated animals demonstrated significant improvements in neuropathic pain measures and functional recovery, had reduced production of TNF-a and IL-1b, reduced macrophage activation, and decreased accumulation of HIF-1a-positive cells compared to non-treated injured animals. The most recent studies using 980 nm wavelength light also have reported effective treatment of neuropathic pain as measured by mechanical and thermal withdrawal threshold. The investigators induced nerve injury with the chronic constriction model, and then treated directly over the incision at 3 points (energy density 4 J/cm 2 , power density 0.248 W/cm 2 , beam area $0.238 cm 2 ) daily for 2 weeks beginning on the day after surgery [41, 42] . These studies reported significant improvements in pain measures at both 7 and 14 days after surgery.
The current study adds to the existing evidence that PBM with near infrared light is an effective treatment for mechanical hypersensitivity in an animal model, given correct dosing parameters. This study also found a positive effect even after mechanical allodynia behavior was fully established, 7 days after initial injury, which may more closely model clinical pain conditions where the pathogenesis of chronic neuropathic pain is initiated. CD86 expression was significantly greater in injured samples in both the SCDC (G) and SCDH (H), with a peak expression at day 14. Sections from PBM treated samples did not differ from sham. PBM resulted in a significant increase in anti-inflammatory M2 macrophage activation in the DRG, which was sustained from day 14 to day 30 (I). **P < 0.01 by 2-way ANOVA, P values corrected for multiple comparisons using Bonferroni-Holm technique. Data in graph are presented as mean þ/À SEM.
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Temporal-Spatial Characterization of Macrophages/ Microglia
The results of this study demonstrate distinct changes in activation of macrophages and microglia labeled with Iba1 along the course of the DC-ML pathway, including a novel characterization of microglial activation in the SCDC. Macrophage activation in the DRG occurred later than CNS microglial activation (at day 7 and 14). Studies of neuropathic pain models other than SNI and in mice have reported an increase in macrophage activation from 3 to 14 days after injury [43, 44] . However, the findings of this study are consistent with other literature that reports a significant increase in macrophage activation that peaks at day 7 after SNI in rats [36, 45] . This discrepancy may be due to inter-species differences or different temporal activation of macrophages responding to patterns of sensory nerve loss dependent on the model. For example, partial sciatic nerve ligation [46] and SNI [34, 38] would have different patterns of ongoing sensory nerve loss continuing weeks after initial injury.
The rapid activation of microglia in the CNS SCDH is well documented in the literature [47] [48] [49] . Microglial activation typically is reported by 3 days and peaks at 7 days, as was found in the current study [35, 43, 47] . The difference in timing between activation at the DRG and SCDH indicates an independent CNS response to peripheral nerve injury that functions apart from the response of the PNS [50] .
The activity of microglia in the SCDC has not been wellcharacterized following peripheral nerve injury. Though the DC-ML neurons do not synapse in the SCDC, we still found a significant increase in activated microglia from 3 to 14 days post surgery in the injured groups, compared to only 3 to 7 days post surgery in the SCDH ( Figure 3H, 3I) . Microglial activation in the SCDC has been reported in animal models other than peripheral nerve injury, and they provide insight into this finding. An increase in expression of markers of activated, phagocytic microglia was reported in the T4-T5 dorsal column following a lesion to the T8 spinal cord in a model of spinal cord injury [51] . OX 41 and OX 18 expression was significantly increased in microglia in the T4-5 fasciculus gracilis 2 and 5 days following spinal cord injury, and those microglia exhibited activated, amoeboid morphology associated with phagocytic function. The SCDC tracts at the T4-5 level were involved in a retrograde response to the injured axons at T8. Though the axon injury in SNI occurs in the distal process of the nerve, it may be plausible that degeneration of the axons of the pseudounipolar neuron causes a sustained inflammatory reaction in the associated dorsal column segment of the spinal cord. This activation of CNS microglia by a PNS injury is not fully understood, but could be caused by changes in impulse conduction [52] [53] [54] .
Finally, this study highlighted the involvement of microglial activation in the GN of the medulla. Remarkably, microglial activation occurred in the GN just 3 days post-operatively, and was sustained until 30 days after the initial injury to the distal nerve. Previous studies using adult, male Sprague-Dawley rats have reported microglial activation in the GN at a single time point following SNI (14 days after injury) [55] and ranging from 3 to 21 days after spinal nerve ligation [56] . Our results support that microglial activation in the GN is implicated in chronic neuropathic pain states.
Except for in the GN at 14 days, there were no significant differences in Iba1 expression between SNI and PBM samples. It is important to note that Iba1 is a general macrophage/microglial marker, which can be used to indicate cell number, size, and morphological changes, but is not a direct correlate of neuropathic pain states [47] . It is possible that there is a difference between the SNI and PBM groups in biological assays that were not measured here, such as pro-and antiinflammatory cytokines, chemokines, growth factors, or receptors that are associated with neuron-glial signaling in neuropathic pain states [5, 57, 58] . The lack of a difference in expression of Iba1 between SNI and PBM samples may also indicate that the mechanistic effect of PBM is occurring at the molecular level. For example, PBM has been shown to cause a significant decrease in IL-1b mRNA in muscle [21] and a decrease in IL-1b, TNF, and IL-6 mRNA expression in wounded skin tissue [59] . Despite the lack of difference between macrophage/microglial Iba1 expression, the clear functional improvement of the PBM group compared to the SNI group indicates that further studies are warranted to more thoroughly investigate pro-and anti-inflammatory cytokines, chemokines, growth factors, and receptors related to neuropathic pain.
Macrophage/Microglia Polarization
This was the first study to evaluate M1/M2 polarization in a rat model of neuropathic pain. The pro-inflammatory M1 phenotype of microglia was increased in SNI samples of SC, but not in PBM or sham samples. This finding is similar to Willemen and colleagues' finding in mice, which reported that a shift to M1 activation in SCDH was associated with increased pain behavior [10] . The shift to M1 activation of macrophages and microglia is associated with increased release of pro-inflammatory factors and expression of receptors implicated in neuropathic pain. For example, M1 microglia have been reported to release TNF-a and IL-1b, which have been implicated in causing enhanced excitation of somatosensory fibers, as well as disinhibition of pain modulation [60] [61] [62] . PBM has been used previous to alter microglial phenotypes across the M1/M2 spectrum in a dose-dependent manner in vitro [23] . Primary microglia and a microglial cell line were exposed in vitro to 808 nm wavelength light. Higher energy densities (4-30 J/cm2) induced expression of the M1 (proinflammatory) phenotype, whereas lower densities (0.2-10 J/ cm 2 ) induced M2 (anti-inflammatory) marker expression. These findings suggest that PBM may be able to be used to modulate the inflammatory response following peripheral nerve injury towards a protective anti-inflammatory activation that could decrease neuropathic pain. The findings of this study support that SNI causes a shift towards proinflammatory microglial activation that may be implicated in establishment and maintenance of neuropathic pain.
Though there were no differences found in the expression of Iba1 between SNI and PBM, there was a significant shift to M2 macrophage activation in the DRG of PBMtreated animals, indicating that PBM treatment does cause a shift towards anti-inflammatory macrophage activation, which leads to resolution of damaging pro-inflammatory processes. It is possible that there are differences between the SNI and PBM groups in biological assays that were not measured here, such as pro-and anti-inflammatory cytokines, chemokines, growth factors, or receptors that are associated with neuron-glial signaling in neuropathic pain states [5, 57, 58] . The lack of a difference in expression of Iba1 between SNI and PBM samples may also indicate that the mechanistic effect of PBM is occurring at the molecular level. For example, PBM has been shown to cause a significant decrease in IL-1b mRNA in muscle [21] and a decrease in IL-1b, TNF, and IL-6 mRNA expression in wounded skin tissue [59] .
One other study has investigated the effect of PBM (660 nm wavelength light) on inflammatory markers in a neuropathic pain model (chronic constriction injury) in adult male Sprague-Dawley rats [42] . Hsieh and colleagues [40] reported a decrease in pro-inflammatory markers (TNF, IL1b, and HIF-1a) at the injury site (sciatic nerve) in PBM treated animals compared to nontreated-injured animals. Both studies provide evidence that PBM is effective for treating neuropathic pain and inflammatory response modulation is a possible explanation of the effectiveness.
The shift to M2 macrophage and microglial activation reported in the present study may be an important link in elucidating the anti-inflammatory mechanism of PBM, and future work should include a more full characterization of inflammatory cytokines, chemokines, growth factors, and receptors at both the molecular and protein level.
Conclusion
Chronic neuropathic pain is a common problem with serious negative outcomes that are challenging to treat. This study provided new insight into the role of activated macrophages and microglia in response to nerve injury, and demonstrated that PBM effectively resolves mechanical hypersensitivity in this model. There was a sustained, region-specific, inflammatory response along the STT and DC-ML pathway. SNI caused a shift to the pro-inflammatory phenotype of microglia in the SCDH, as well as in the SCDC. The PBM treated animals did not have an increase in microglia expressing markers of the pro-inflammatory phenotype. Furthermore, PBM caused a shift to the protective, anti-inflammatory, M2 phenotype, in the cell bodies of the injured peripheral nerves, but not in sham or injured samples. This study demonstrated the effectiveness of PBM as a treatment for mechanical hypersensitivity and establishes a foundation for future work on the role of macrophage and microglia activation in the formation of neuropathic pain.
